Regulate Synthetic Biology Now: 194 Countries
By SynBioWatch,
SynBioWatch
| 10. 17. 2014
PYEONGCHANG, SOUTH KOREA– In a unanimous decision of 194 countries, the United Nation’s Convention on Biological Diversity (CBD) today formally urged nation states to regulate synthetic biology (SynBio), a new extreme form of genetic engineering. The landmark decision follows ten days of hard-fought negotiations between developing countries and a small group of wealthy biotech-friendly economies. Until now, synthetic organisms have been developed and commercialized without international regulations; increasing numbers of synthetically-derived products are making their way to market. The CBD’s decision is regarded as a “starting signal” for governments to begin establishing formal oversight for this exploding and controversial field.
“Synthetic Biology has been like the wild west: a risky technology frontier with little oversight or regulation,” Jim Thomas of ETC Group explained from CBD negotiations in Korea. “At last the UN is laying down the law.”
“This international decision is very clear,” Thomas added. “Not only do countries now have to set up the means to regulate synthetic biology, but those regulations need to be based on precaution and not harming the environment.”
“The good news is that precaution...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Andrew Gregory, The Guardian | 01.11.2026
Google has removed some of its artificial intelligence health summaries after a Guardian investigation found people were being put at risk of harm by false and misleading information.
The company has said its AI Overviews, which use generative AI to...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
By Katherine Long, The Wall Street Journal | 12.27.2025
Nia Trent-Wilson owes $182,889.63 in medical bills for a baby that wasn’t hers.
In late 2021, she agreed to act as a surrogate through an agency that paired her with a gay couple from Washington, D.C. The terms were typical...